U.S. Stem Cell, Inc.
USRM
$0.00
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 20.00K | 14.20K | 24.50K | 23.30K | 23.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.00K | 14.20K | 24.50K | 23.30K | 23.60K |
| Cost of Revenue | 4.90K | 5.30K | 6.20K | 7.30K | 8.60K |
| Gross Profit | 15.10K | 9.00K | 18.30K | 16.00K | 15.00K |
| SG&A Expenses | 389.30K | 405.60K | 453.30K | 530.60K | 377.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 394.20K | 410.80K | 459.60K | 537.90K | 386.20K |
| Operating Income | -374.20K | -396.60K | -435.00K | -514.60K | -362.70K |
| Income Before Tax | -566.60K | -565.40K | -570.10K | -1.16M | -641.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -566.60K | -565.40K | -570.10K | -1.16M | -641.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -566.60K | -565.40K | -570.10K | -1.16M | -641.00K |
| EBIT | -374.20K | -396.60K | -435.00K | -514.60K | -362.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 634.85M | 609.39M | 597.33M | 523.73M | 491.09M |
| Average Diluted Shares Outstanding | 634.85M | 609.39M | 597.33M | 523.73M | 491.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
